Daewoo Pharmaceutical Ind. Co., Ltd.

Calculating rank

USPTO Granted Patents = 2

% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 0

Loading Chart...

9 inventors (with patents filed for the assignee):

Dong-Hee Kim (2 out of 115 patents)

Young-Hoon Ji (2 out of 2 patents)

Jae-Seon Kang (2 out of 2 patents)

4. Sung-Uk Chung (2 out of 2 patents)

5. Sung-Woo Hwang (2 out of 2 patents)

6. Kyung-Ran Kang (2 out of 2 patents)

7. Jung-Ae Kim (1 out of 4 patents)

8. Chun-Gyu Kim (1 out of 1 patent)

9. You-Ra Kang (1 out of 1 patent)

2 patents: Sort by Forward Citations

1. 9089543 - Anti-inflammatory composition containing macrolactin A and a derivative thereof as active ingredients (2015-07-28),

2. 8940788 - Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients (2015-01-27),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2 Patents

#82 in Busan

#3,804 in South Korea

Busan, South Korea

Daewoo Pharmaceutical Ind. Co., Ltd.

Forward Citations = 0

9 inventors:

Dong-Hee Kim (2 out of 115 patents)

Young-Hoon Ji (2 out of 2 patents)

Jae-Seon Kang (2 out of 2 patents)

4. Sung-Uk Chung (2 out of 2 patents)

5. Sung-Woo Hwang (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Daewoo Pharmaceutical Ind. Co., Ltd.. Retrieved from https://idiyas.com/company/daewoo-pharmaceutical-ind-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]